Dr. Uihlein is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
91 43rd St
Helomics Corp
Pittsburgh, PA 15201Phone+1 800-547-6165- Is this information wrong?
Education & Training
- Allegheny Health Network Medical Education Consortium (AGH)Residency, Pathology-Anatomic and Clinical, 2005 - 2010
- Allegheny Health Network Medical Education Consortium (AGH)Fellowship, Cytopathology, 2008 - 2009
- TriHealth (Bethesda North Hospital)Residency, Family Medicine, 1990 - 1991
- University of ToledoResidency, Family Medicine, 1988 - 1990
- The University of Toledo College of MedicineClass of 1988
Certifications & Licensure
- OH State Medical License 1990 - 2025
- PA State Medical License 1999 - 2024
- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
- American Board of Pathology Cytopathology
Publications & Presentations
PubMed
- 4 citationsPredicting Prognosis of Early-Stage Non-Small Cell Lung Cancer Using the GeneFx® Lung Signature.Sandy D. Der, Chang-Qi Zhu, Stacey L. Brower, Arlette H. Uihlein> ;Plos Currents. 2015 Oct 26
- 8 citationsAnalytical Performance of a 15-Gene Prognostic Assay for Early-Stage Non-Small-Cell Lung Carcinoma Using RNA-Stabilized Tissue.Shuguang Huang, Nicholas J. Reitze, Amy L. Ewing, Suzanne M. McCreary, Arlette H. Uihlein, Stacey L. Brower, Dakun Wang, Tianhua Wang, Michael J. Gabrin, Katherine E. ...> ;The Journal of Molecular Diagnostics. 2015 Jul 1
Press Mentions
- Predictive Oncology Inc. (NASDAQ: POAI) Subsidiary Helomics Continues Progress Toward AI-Driven Predictive Model of Ovarian CancerApril 9th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: